LGND - CIK 0000886163
LIGAND PHARMACEUTICALS INC has filed 2,226 documents with the SEC between 1994 and 2026. The most frequent type is insider trade (886 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2021-02-09 | 2021-02-05 |
| Passive ownership stake | SC 13G | 2021-02-09 | - |
| Passive ownership stake (update) | SC 13G/A | 2021-02-08 | - |
| Insider trade | 4 | 2021-02-05 | 2021-02-03 |
| Insider trade | 4 | 2021-02-05 | 2021-02-03 |
| Insider trade | 4 | 2021-02-05 | 2021-02-03 |
| Insider trade | 4 | 2021-02-05 | 2021-02-03 |
| Major company event | 8-K | 2021-02-03 | 2021-02-03 |
| Major company event | 8-K | 2021-01-28 | 2021-01-25 |
| Employee stock plan | S-8 | 2021-01-27 | - |
| Insider trade | 4 | 2021-01-27 | 2021-01-25 |
| Insider trade | 4 | 2021-01-27 | 2021-01-25 |
| Insider trade | 4 | 2021-01-27 | 2021-01-25 |
| Insider trade | 4 | 2021-01-27 | 2021-01-25 |
| Insider trade | 4 | 2021-01-27 | 2021-01-27 |
| Passive ownership stake (update) | SC 13G/A | 2021-01-27 | - |
| Passive ownership stake (update) | SC 13G/A | 2021-01-15 | - |
| SEC correspondence | UPLOAD | 2021-01-13 | - |
| Company correspondence | CORRESP | 2021-01-06 | - |
| Insider trade | 4 | 2021-01-05 | 2020-12-31 |
| SEC correspondence | UPLOAD | 2020-12-23 | - |
| Major company event | 8-K | 2020-12-21 | 2020-12-18 |
| Major company event | 8-K | 2020-12-16 | 2020-12-15 |
| Major company event (amended) | 8-K/A | 2020-12-10 | 2020-10-01 |
| Insider trade | 4 | 2020-12-09 | 2020-12-08 |
| Major company event | 8-K | 2020-12-03 | 2020-12-02 |
| Major company event | 8-K | 2020-11-23 | 2020-11-23 |
| Proxy statement | DEF 14A | 2020-11-12 | 2020-12-15 |
| Insider trade | 4 | 2020-11-10 | 2020-11-09 |
| Quarterly report | 10-Q | 2020-11-06 | 2020-09-30 |
| Insider trade | 4 | 2020-11-04 | 2020-11-02 |
| PRE 14A | - | 2020-10-30 | 2020-12-15 |
| Major company event | 8-K | 2020-10-30 | 2020-10-26 |
| Major company event | 8-K | 2020-10-30 | 2020-10-30 |
| Major company event | 8-K | 2020-10-20 | 2020-10-20 |
| Major company event | 8-K | 2020-10-13 | 2020-10-11 |
| New insider ownership | 3 | 2020-10-09 | 2020-10-01 |
| Passive ownership stake (update) | SC 13G/A | 2020-10-08 | - |
| Major company event | 8-K | 2020-10-01 | 2020-10-01 |
| SC TO-T/A | - | 2020-09-30 | - |
| Major company event | 8-K | 2020-09-23 | 2020-09-21 |
| Company correspondence | CORRESP | 2020-09-16 | - |
| SC TO-T/A | - | 2020-09-16 | - |
| SC TO-T/A | - | 2020-09-11 | - |
| Major company event | 8-K | 2020-09-10 | 2020-09-08 |
| SC TO-T | - | 2020-08-31 | - |
| Insider trade | 4 | 2020-08-25 | 2020-08-21 |
| SC TO-C | - | 2020-08-11 | - |
| SC TO-C | - | 2020-08-11 | - |
| Major company event | 8-K | 2020-08-11 | 2020-08-10 |